Attorney General Tom Corbett said Pennsylvania will receive $1 million of a nationwide $75 million settlement related to off-label marketing of migraine medication Topamax.

The settlement was reached with Ortho-McNeil-Janssen Pharmaceuticals Inc., a part of Johnson & Johnson, which has operations in the Philadelphia area.

Corbett said the settlement resolves allegations that the company marketed the drug for psychiatric conditions beyond those approved by U.S. Food and Drug Administration.

The off-label conditions the drug was prescribed for included bipolar disorder and drug addiction.    - Bob Fernandez